Can-Fite BioPharma Ltd.

Regulatory Filings • Aug 25, 2022

_________ false

��-���� ������� ��"�	2 381
CAN-FITE BIOPHARMA LTD
Corporation no: 512022153	4330
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	25/08/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-108250	Time of broadcast: 11:53 11:53

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Financial results for the six months ended June 30, 2022 and updates on its drug development programs and an unaudited interim condensed consolidated financial statements as of June 30, 2022.

ea164764-6k_canfiteEDGAR6_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 02/08/2022
Address: Bareket 10 , Petach-Tikva 47190   , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378
E-mail address: motti@canfite.co.il   Company site: www.canfite.com
Previous names of reporting entity:
Name of the Signatory: FISHMAN PNINA Position of Signatory in the reporting corporation: Director, CFO Name of Employer Company:
Address: BAR-ON 2 , HERZLIA 4658084 Telephone: 03-9241114 Facsimile: 03-9249378 E-mail: pnina@canfite.co.il 2